None of the patients with an sFlt-1/PlGF ratio below 33 who developed preeclampsia developed eclampsia, HELLP syndrome, or experienced any other clinical important negative outcome for the mother or the neonate, with the exception of one case of a small-for-gestational-age baby. This evidence concerns the gene PGF and preeclampsia.